相关实验视频

Updated: Jul 20, 2026

Generating Recombinant Avian Herpesvirus Vectors with CRISPR/Cas9 Gene Editing
12:21

Generating Recombinant Avian Herpesvirus Vectors with CRISPR/Cas9 Gene Editing

Published on: January 7, 2019

13.2K

产生MVA-Vector疫苗候选物并在动物模型中测试它们

Alina Tscherne1, Christian Meyer Zu Natrup2, Georgia Kalodimou1

  • 1Division of Virology, Department of Veterinary Science, LMU Munich, Oberschleißheim, Germany.

Methods in molecular biology (Clifton, N.J.)
|December 2, 2024
PubMed
概括

修改的疫苗病毒安卡拉 (MVA) 是一种安全的,复制不足的病毒,非常适合疫苗开发. 本章详细介绍了用于研究和临床使用的MVA载体的创建和生产协议.

关键词:
动物模型动物模型临床前测试 临床前测试疫苗病毒是疫苗病毒.病毒载体疫苗 病毒载体疫苗

更多相关视频

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.4K
Rapid, Seamless Generation of Recombinant Poxviruses using Host Range and Visual Selection09:25

Rapid, Seamless Generation of Recombinant Poxviruses using Host Range and Visual Selection

Published on: May 24, 2020

5.2K

相关概念视频

Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...